- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1383EUR$1,400USD£1,151GBP
€1976EUR$2,000USD£1,645GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1383EUR$1,400USD£1,151GBP
€1976EUR$2,000USD£1,645GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1383EUR$1,400USD£1,151GBP
€1976EUR$2,000USD£1,645GBP
- Clinical Trials
- April 2024
- 107 Pages
Global
From €1383EUR$1,400USD£1,151GBP
€1976EUR$2,000USD£1,645GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1383EUR$1,400USD£1,151GBP
€1976EUR$2,000USD£1,645GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1037EUR$1,050USD£864GBP
€1482EUR$1,500USD£1,234GBP
- Clinical Trials
- April 2024
- 50 Pages
Global
From €865EUR$875USD£720GBP
€1235EUR$1,250USD£1,028GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1383EUR$1,400USD£1,151GBP
€1976EUR$2,000USD£1,645GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1383EUR$1,400USD£1,151GBP
€1976EUR$2,000USD£1,645GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1383EUR$1,400USD£1,151GBP
€1976EUR$2,000USD£1,645GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1383EUR$1,400USD£1,151GBP
€1976EUR$2,000USD£1,645GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €865EUR$875USD£720GBP
€1235EUR$1,250USD£1,028GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €865EUR$875USD£720GBP
€1235EUR$1,250USD£1,028GBP
- Report
- May 2024
- 180 Pages
Global
From €4446EUR$4,500USD£3,701GBP
- Report
- July 2024
- 100 Pages
Global
From €2594EUR$2,625USD£2,159GBP
€3705EUR$3,750USD£3,084GBP
- Report
- July 2024
- 150 Pages
Global
From €2594EUR$2,625USD£2,159GBP
€3705EUR$3,750USD£3,084GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €2594EUR$2,625USD£2,159GBP
€3705EUR$3,750USD£3,084GBP
- Report
- June 2024
- 200 Pages
Global
From €5499EUR$5,565USD£4,577GBP
€7855EUR$7,950USD£6,538GBP
- Report
- June 2024
- 200 Pages
Global
From €5499EUR$5,565USD£4,577GBP
€7855EUR$7,950USD£6,538GBP
- Report
- June 2024
- 200 Pages
Global
From €5499EUR$5,565USD£4,577GBP
€7855EUR$7,950USD£6,538GBP
The Sexual and Reproductive Health Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs and treatments related to sexual and reproductive health. These drugs are used to treat conditions such as infertility, erectile dysfunction, and contraception. They also include treatments for sexually transmitted infections, such as HIV and HPV.
The market is highly competitive, with many companies offering a range of products and services. Some of the major players in the market include Pfizer, Merck, Bayer, and GSK. These companies are involved in the research and development of new drugs and treatments, as well as the marketing and distribution of existing products. Other companies in the market include Allergan, Teva, and Mylan. Show Less Read more